Nasdaq News

Key PointsTech giants are committing more capital to robotics, an industry that may surge thanks to artificial intelligence.

(RTTNews) - Acuity Inc. (AYI) announced earnings for its fourth quarter that Increases, from the same period last year

Key PointsThe WisdomTree U.S. Quality Dividend Growth Fund isn’t much in the yield department, but it offers plenty of other advantages.

(RTTNews) - Ion Beam Applications S.A. (IBAB.BR), a medical technology company, on Thursday announced a new agreement with ARTMS Inc., a subsidiary of Telix Pharmaceuticals Inc. (TLX) to distribute its Quantum Irradiation System (QIS) to promote theranostics.

Key PointsBecause of a brutal price war and increasing competition in China, Tesla has focused on exports in Asia.

Key PointsEven if you put money to work just before the last bear market started, in theory making a terrible timing call, you’d have captured a 73% total return.

(RTTNews) - Germany's equity benchmark DAX fell to a near 9-week low on Thursday as stocks tumbled on inflation and interest rate concerns amid elevated oil prices and bond yields due to persisting geopolitical tensions.

Key PointsPershing Square sold out of its entire Alphabet position in favor of Microsoft.

(RTTNews) - CollPlant Biotechnologies Ltd(CLGN), a regenerative medicine and technology company, announced its second-quarter 2026 financial results, reflecting a narrower net loss.

Key PointsThe median U.S. household spends $363 per month, or $4,356 per year, on utilities.

(RTTNews) - Thursday, Zealand Pharma A/S (ZEAL.CO) announced new Phase 3 data for Survodutide, an investigational once-weekly glucagon/GLP-1 receptor dual agonist in patients with obesity, and type 2 diabetes (T2D).

Key PointsGreg Abel wasted little time shaking up Berkshire’s $358 billion investment portfolio in the wake of Warren Buffett’s Dec. 31 retirement.

Key PointsThe Grayscale Zcash ETF is off to an impressive start.

Key PointsDeveloping new global partnerships, where former leadership preferred an insular approach, is a great shift.

Key PointsNvidia expects to grow at a strong pace again in 2027.

(RTTNews) - The following biotech stocks reached a 52-week high on September 30, 2026, driven by key catalysts such as promising results from clinical trials.

Key PointsTwenty-four of 32 analysts covering Intuitive Surgical rate the stock as a "buy" or "strong buy."

(RTTNews) - PZ Cussons plc (PZC.L), a consumer goods company, on Thursday reported 4.5 percent like-for-like revenue growth in the first quarter of fiscal 2027.

Key PointsThree hundred monthly purchases of $500 each, starting in October 2001, totaled $150,000 in contributions.

(RTTNews) - Pliant Therapeutics (PLRX), a clinical-stage biotechnology company focused on developing integrin-based therapeutics, announced the appointment of David Raben, M.D., as Chief Medical Officer.